DekaBank Deutsche Girozentrale’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.1M Hold
113,193
0.06% 242
2025
Q4
$18.2M Hold
113,193
0.03% 351
2025
Q3
$50.3M Hold
113,193
0.08% 212
2025
Q2
$36.5M Buy
113,193
+151
+0.1% +$41.8K 0.07% 239
2025
Q1
$30M Sell
113,042
-151
-0.1% -$38.8K 0.06% 254
2024
Q4
$26.5M Hold
113,193
0.05% 278
2024
Q3
$30.9M Sell
113,193
-270
-0.2% -$70.3K 0.06% 261
2024
Q2
$27.9M Buy
113,463
+421
+0.4% +$66.5K 0.05% 266
2024
Q1
$17.3M Sell
113,042
-24,843
-18% -$4.14M 0.03% 347
2023
Q4
$26.8M Sell
137,885
-5,215
-4% -$888K 0.06% 274
2023
Q3
$24.8M Sell
143,100
-17,349
-11% -$3.31M 0.06% 277
2023
Q2
$30.6M Buy
160,449
+36,404
+29% +$7.22M 0.07% 253
2023
Q1
$24M Buy
124,045
+33,692
+37% +$7.08M 0.06% 272
2022
Q4
$21.3M Buy
90,353
+1,962
+2% +$418K 0.06% 277
2022
Q3
$18.4M Buy
88,391
+18,804
+27% +$3.59M 0.05% 275
2022
Q2
$9.98M Buy
69,587
+12,419
+22% +$1.76M 0.03% 385
2022
Q1
$9.52M Buy
57,168
+889
+2% +$135K 0.02% 432
2021
Q4
$9.54M Buy
56,279
+11,843
+27% +$2.2M 0.02% 429
2021
Q3
$7.9M Sell
44,436
-29,155
-40% -$5.47M 0.02% 432
2021
Q2
$12.1M Sell
73,591
-104
-0.1% -$15.2K 0.04% 337
2021
Q1
$9.91M Buy
73,695
+2,047
+3% +$308K 0.03% 356
2020
Q4
$9.32M Sell
71,648
-10,540
-13% -$1.41M 0.04% 335
2020
Q3
$12M Buy
82,188
+74,464
+964% +$10.6M 0.05% 262
2020
Q2
$1.14M Buy
7,724
+1,685
+28% +$227K 0.01% 624
2020
Q1
$650K Sell
6,039
-239
-4% -$27.6K 0.01% 700
2019
Q4
$731K Sell
6,278
-52,301
-89% -$5.21M ﹤0.01% 762
2019
Q3
$4.76M Sell
58,579
-51,300
-47% -$4.06M 0.03% 360
2019
Q2
$7.84M Buy
109,879
+64,339
+141% +$4.94M 0.04% 348
2019
Q1
$5.61M Buy
45,540
+9,428
+26% +$789K 0.03% 403
2018
Q4
$2.53M Sell
36,112
-9,428
-21% -$725K 0.02% 489
2018
Q3
$5.61M Sell
45,540
-7,588
-14% -$763K 0.03% 408
2018
Q2
$5.24M Sell
53,128
-12,978
-20% -$1.29M 0.03% 384
2018
Q1
$8.64M Buy
66,106
+6,246
+10% +$805K 0.06% 311
2017
Q4
$4.86M Hold
59,860
0.04% 379
2017
Q3
$4.86M Sell
59,860
-5,500
-8% -$469K 0.04% 381
2017
Q2
$5.14M Hold
65,360
0.04% 374
2017
Q1
$3.34M Buy
65,360
+24,850
+61% +$1.15M 0.03% 413
2016
Q4
$1.62M Buy
40,510
+676
+2% +$28.3K 0.02% 470
2016
Q3
$2.78M Sell
39,834
-700
-2% -$49.4K 0.03% 403
2016
Q2
$2.25M Sell
40,534
-1,450
-3% -$91.4K 0.03% 444
2016
Q1
$2.49M Sell
41,984
-10,090
-19% -$671K 0.03% 425
2015
Q4
$4.92M Buy
52,074
+550
+1% +$51K 0.06% 321
2015
Q3
$4.14M Buy
51,524
+2,824
+6% +$314K 0.05% 344
2015
Q2
$5.84M Buy
48,700
+9,430
+24% +$1.13M 0.07% 270
2015
Q1
$4.1M Sell
39,270
-1,680
-4% -$170K 0.05% 351
2014
Q4
$3.97M Sell
40,950
-3,750
-8% -$347K 0.05% 348
2014
Q3
$3.49M Buy
44,700
+1,350
+3% +$87.1K 0.05% 337
2014
Q2
$2.74M Buy
43,350
+5,550
+15% +$330K 0.04% 363
2014
Q1
$2.54M Buy
37,800
+1,900
+5% +$147K 0.04% 348
2013
Q4
$2.32M Buy
35,900
+1,200
+3% +$71.6K 0.04% 303
2013
Q3
$2.22M Buy
+34,700
New +$1.73M 0.04% 307

Other funds holding ALNY